It has been suggested by experimental evidences that ERBB2 was involved in the regulation of antioxidant defenses in cancer and the protection against cardiomyocyte oxidative stress and death, which was due to pathways that converged on preventing oxidative stress and induced further activation and upregulation by the upregulation of ERBB2 (77). The gene discussed is ERBB2; the disease is cancer.